Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Summary

This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the organs and tissue of the human body during x-ray, CT-scan or MRI investigations, doctors are using contrast media (a kind of dye) which can be given to patients by injection into a blood vessel or by mouth.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Motor Function
• Cognitive Function
• Contrast Media

Eligibility basics and study details

Study type

Interventional

Phase

Phase 4

Ages

18 to 64 years

Sex

All

Healthy volunteers

Not accepted

Sponsor

Guerbet

Last updated on ClinicalTrials.gov

January 22, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites